Azade Kanat

4PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursAllergyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 22, 2026
Uncommon Presentation of Mycoplasma pneumoniae: Rash and Mucositis Manifestation.

|Dec 23, 2025
Risk Factors for Infectious Adverse Events in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Venetoclax Combinations: A Retrospective Single-Centre Real-World Experience.

Olgu Erkin Çınar, Azade Kanat, Kerim Erer

|Nov 12, 2025
Tuberculous Meningitis With Paradoxical Reaction in an Immunocompetent Young Male Treated by Interleukin-1 Receptor Antagonist.

Azade Kanat, Ayşin Kılınç Toker, Zuhal Özer Şimşek

|Oct 29, 2021
Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia.

Ilhami Celik, Esma Eryilmaz-Eren, Aysin Kilinc-Toker

Pageof 1

Frequent Collaborators

3 joint publications

Ilhami Celik

3 joint publications

Esma Eryılmaz-Eren

2 joint publications

Ayşin Kılınç Toker

1 joint publications

Didem Eren